Equities

Myomo Inc

Myomo Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)3.64
  • Today's Change-0.04 / -1.09%
  • Shares traded149.40k
  • 1 Year change+672.82%
  • Beta1.4690
Data delayed at least 15 minutes, as of May 17 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.

  • Revenue in USD (TTM)19.55m
  • Net income in USD-9.34m
  • Incorporated2004
  • Employees101.00
  • Location
    Myomo Inc137 Portland Street, 4Th FloorBOSTON 02114United StatesUSA
  • Phone+1 (617) 996-9058
  • Fax+1 (302) 655-5049
  • Websitehttps://myomo.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Pro-Dex Inc48.24m5.00m68.21m146.0014.352.2211.281.411.391.3913.448.980.97462.303.68330,438.3010.1115.4312.9418.8728.2533.1510.3714.922.16--0.27530.009.6215.4654.7232.380.8422--
Asensus Surgical Inc8.72m-78.71m71.21m207.00--5.46--8.16-0.3065-0.30650.03390.04790.12711.7913.0942,144.93-114.63-71.10-146.89-79.04-52.04-71.39-902.25-1,207.710.689--0.00--21.02-18.67-3.80---6.14--
Vivos Inc18.00k-3.20m73.83m10.00--55.03--4,101.69-0.0087-0.00870.000050.00340.0127--3.13---225.38-202.25-235.64-552.77-33.3310.79-17,805.45-11,969.07----0.00---46.58---17.19------
Neuronetics Inc73.23m-27.54m75.59m202.00--2.73--1.03-0.9484-0.94842.520.92260.70612.265.43360,714.30-26.56-28.02-30.98-34.7375.5275.73-37.61-51.045.18-4.270.6825--9.426.2218.76--18.57--
T2 Biosystems Inc7.18m-45.65m86.66m113.00------12.08-17.91-17.912.21-6.850.24973.244.9363,504.43-158.80-106.01---253.03-116.97-12.60-636.09-317.930.1936--10.70---67.75-7.2919.66---20.19--
Xtant Medical Holdings Inc91.30m660.00k90.16m207.00--1.7623.520.9875-0.0042-0.00420.7550.39451.191.325.78441,072.500.8636-10.381.15-14.6860.7561.080.7229-8.661.22-4.020.2997--57.504.81107.78--18.47--
Akso Health Group - ADR2.20m-17.07m94.07m12.00------42.71-0.7466-0.24610.0963--0.11661.910.3202183,560.00-89.84-17.36-224.28-23.997.56---770.59-256.641.36-24.020.6531--119.69-34.25-221.68------
Vuzix Corp9.94m-49.96m97.09m94.00--1.33--9.77-0.7826-0.78260.15581.130.09971.302.52105,762.30-50.09-41.61-54.56-44.80-35.85-6.13-502.49-317.286.57--0.00--2.488.42-23.02--39.42--
Sensus Healthcare Inc31.66m4.65m105.25m35.0022.522.0621.373.320.28510.28511.943.120.57211.021.96904,428.608.4110.299.4012.1460.3462.8514.7015.296.49--0.00---45.20-1.58-98.00---23.16--
Fonar Corp102.42m12.16m105.42m561.009.010.64335.071.031.741.7414.6024.420.512420.351.44182,570.608.338.738.649.6045.6748.3316.2516.399.15--0.0055--1.083.89-24.71-15.058.48--
Myomo Inc19.55m-9.34m106.04m101.00--9.72--5.42-0.2676-0.26760.57750.37861.293.2312.10193,552.80-61.73-81.78-89.94-115.2767.3968.50-47.77-85.762.40--0.00--23.7051.0924.00--2.82--
KORU Medical Systems Inc29.32m-13.27m108.00m82.00--5.64--3.68-0.2905-0.29050.64220.41810.89192.386.85357,595.80-40.35-17.60-47.06-20.2960.2459.44-45.24-21.703.37--0.0284--2.2310.44-58.65--11.10--
Vivani Medical Inc0.00-25.65m108.31m44.00--4.84-----0.5042-0.50420.000.40680.00----0.00-52.93-56.58-60.80-67.66-------2,868.72----0.00-------84.69--40.33--
InfuSystem Holdings Inc127.41m84.00k135.01m499.002,280.582.5810.981.060.00280.00285.912.461.2310.666.57255,330.700.08114.600.09555.6950.2756.430.06594.071.511.560.36410.0014.4413.384,744.44--6.01--
Akoya Biosciences Inc93.57m-68.01m143.09m330.00--4.37--1.53-1.47-1.471.990.66320.60562.207.08283,554.50-44.01---56.06--55.99---72.68--2.38-10.150.7013--29.09--10.36------
Data as of May 17 2024. Currency figures normalised to Myomo Inc's reporting currency: US Dollar USD

Institutional shareholders

35.63%Per cent of shares held by top holders
HolderShares% Held
AIGH Capital Management LLCas of 16 Jan 20242.84m9.96%
Rosalind Advisors, Inc.as of 31 Mar 20242.45m8.59%
Worth Venture Partners LLCas of 31 Dec 20231.40m4.91%
The Vanguard Group, Inc.as of 31 Mar 20241.16m4.06%
Herr Investment Group LLCas of 31 Dec 2023980.50k3.44%
Essex Investment Management Co. LLCas of 31 Mar 2024602.74k2.12%
Legato Capital Management LLCas of 31 Mar 2024217.53k0.76%
Renaissance Technologies LLCas of 31 Dec 2023193.60k0.68%
Geode Capital Management LLCas of 31 Dec 2023191.21k0.67%
EAM Investors LLCas of 31 Dec 2023126.21k0.44%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.